Currently viewing the tag: "homogenous test"

2014 – a threat for Bioporto, the NGAL-patent or the NGAL-test ??

By On 12. April 2012 · 4 Comments · In BioPorto

Uncertainty about consequences of the recent decision by  the European Patent Organisation’s  (EPO)  Opposition Division (OD) on the NGAL patent Is the ruling really vital for BioPorto … and in case it is not  – why is it not so ? While we are still (after 8 weeks) sitting waiting for the EPO – OD’s […]

Continue Reading →

Todays setback.. what does it mean ?

By On 8. February 2012 · 1 Comment · In BioPorto

Unofficial translation of todays annoncement :

BioPortos NGAL cutoff patent EP1831699, issued in Europe  november 2010, is provisionally rejected by the Opposition Division at the European Patent Organisation held in Den Haag (Holland) earlier today . BioPorto and Høiberg (The Patent advisor) finds the ruling erroneous and is therefore immediately appealing the decision; until the appeal […]

Continue Reading →

Homogenous versus Heterogenous NGAL Testing

By On 26. January 2012 · Leave a Comment · In BioPorto

In the public chatroom Ann asked a very good question:

User Ann: “Could you please elaborate a little bit on the technical difference between the homogeneous and heterogeneous NGAL test? Is it just a matter of marketing or is there a real technical difference in the product?”

I’ve taken the liberty […]

Continue Reading →
Set your Twitter account name in your settings to use the TwitterBar Section.